Mackenzie Financial’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,526
Closed -$266K 1430
2025
Q4
$266K Sell
14,526
-319
-2% -$5.38K ﹤0.01% 1430
2025
Q3
$218K Sell
14,845
-3,234
-18% -$55.4K ﹤0.01% 1529
2025
Q2
$329K Sell
18,079
-50,594
-74% -$1.03M ﹤0.01% 1361
2025
Q1
$1.36M Sell
68,673
-5,866
-8% -$101K ﹤0.01% 892
2024
Q4
$1.28M Buy
74,539
+50,660
+212% +$953K ﹤0.01% 884
2024
Q3
$477K Buy
23,879
+1,190
+5% +$18.5K ﹤0.01% 1034
2024
Q2
$254K Buy
22,689
+507
+2% +$4.25K ﹤0.01% 1244
2024
Q1
$146K Buy
22,182
+1,380
+7% +$7.54K ﹤0.01% 1389
2023
Q4
$94K Hold
20,802
﹤0.01% 1415
2023
Q3
$69.3K Hold
20,802
﹤0.01% 1384
2023
Q2
$76.3K Buy
20,802
+8,567
+70% +$31.8K ﹤0.01% 1427
2023
Q1
$40.5K Buy
12,235
+700
+6% +$2.42K ﹤0.01% 1453
2022
Q4
$44.8K Sell
11,535
-700
-6% -$2.16K ﹤0.01% 1357
2022
Q3
$30K Sell
12,235
-518
-4% -$1.24K ﹤0.01% 1391
2022
Q2
$258K Buy
+12,753
New +$25.1K ﹤0.01% 1160

Other funds holding ADMA